A PHASE IIA MULTICENTER OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF BL-8040 AND PEMBROLIZUMAB IN SUBJECTS WITH METASTATIC PANCREATIC CANCER THE COMBAT STUDY
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
